Case Reports in Infectious Diseases

Volume 2013 (2013), Article ID 929615, 4 pages

http://dx.doi.org/10.1155/2013/929615

Case Report

Recurrent Mitral Valve Endocarditis Caused by Streptococcus pneumoniae in a Splenectomized Host

Shikha Shrestha,¹ JayaKrishna Chintanaboina,1,2 and Samir Pancholy¹

¹Wright Center for Graduate Medical Education, 501 Madison Avenue, Scranton, PA 18510, USA

²Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033, USA

Received 3 November 2013; Accepted 2 December 2013

Academic Editors: P. Domingo, M. Ghate, C. L. Gibert, and C. G. Meyer

Copyright © 2013 Shikha Shrestha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

A 72-year-old male with a remote history of splenectomy and two previous episodes of pneumococcal endocarditis of mitral valve presented with high-grade fever and confusion for 3 days. Nine months priorly, patient underwent mitral valve repair when he had the first episode of pneumococcal mitral valve endocarditis. He received pneumococcal vaccination two years ago. On examination during this admission, he was found to be febrile (104.3 F) and confused and had a grade 2/6 systolic murmur at the apex without any radiation. Laboratory data was significant for a white blood cell count of 22,000/mm³ (normal: 4000–11000/mm³). Blood cultures (4/4 bottles) grew penicillin-sensitive Streptococcus pneumoniae. Transesophageal echocardiogram revealed small vegetation on the posterior mitral leaflet without any evidence of abscess and severe mitral regurgitation. Patient clinically responded to intravenous ceftriaxone. However, due to recurrent pneumococcal mitral valve endocarditis and severe mitral regurgitation, the patient underwent mitral valve replacement. Patient had an uneventful recovery and was discharged home. Pneumococcal endocarditis itself is being uncommon in this current, penicillin, era; our case highlights the recurrent nature of pneumococcal endocarditis in a splenectomized host and the importance of pursuing aggressive treatment options in this clinical scenario.

1. Introduction

Pneumococcal endocarditis (PE) has become relatively uncommon since the advent of penicillin. However, it is a clinically relevant disease because of its significant mortality rate which ranges between 25 and 50% [1]. Although pneumococcal bacteremia is quite common in immunosuppressed/splenectomized patients, the incidence of pneumococcal endocarditis itself is very rare in this group of patients [2]. We report a case of recurrent pneumococcal mitral valve endocarditis in a splenectomized patient.

2. Case Report

A 72-year-old male with a remote history of splenectomy secondary to Hodgkin’s lymphoma, paroxysmal atrial fibrillation (on anticoagulation), coronary artery disease status after coronary artery bypass graft (X1 vessel), and hypertension presented with high-grade fever and confusion for 3 days. He had similar complaints 9 months prior, at which time he was diagnosed with pneumococcal meningitis and pneumococcal mitral valve endocarditis (often referred to as Austrian syndrome). During that time, a transesophageal echocardiogram (TEE) showed mitral valve vegetation and posterior annular abscess. Blood cultures grew penicillin-sensitive Streptococcus pneumoniae. He underwent mitral valve repair, which consisted of P2 resection with the vegetation and repair of the posterior annular abscess at the hospital of the University of Pennsylvania (HUP). Five months later, he was again diagnosed with penicillin-sensitive pneumococcal mitral valve endocarditis; however, he responded promptly to medical therapy with ceftriaxone given intravenously over a 6-week period. He had received a pneumococcal vaccination 2 years prior to this presentation. On physical examination during this admission, he was alert but disoriented to time, place and person. The temperature was 104.3°F, blood pressure 120/74 mm Hg, heart rate 87/minute, and respiratory rate 22/minute. Cardiac auscultation revealed a soft S1 and grade 2/6 systolic murmur at the mitral area without any radiation. There were no meningeal signs, focal neurological deficits, or peripheral stigmata of infective endocarditis. Laboratory data is shown in Table 1. Chest X-ray and urinalysis were normal. Electrocardiogram showed an old left bundle branch block. Computed tomography of head was normal. The patient was initially started on intravenous ampicillin, ceftriaxone, and vancomycin while waiting for blood cultures. Lumbar puncture was not performed on admission due to the risk of bleeding as the patient was on coumadin (INR-2.3). Blood cultures (4/4 cultures) grew penicillin-sensitive Streptococcus pneumoniae. Ampicillin and vancomycin were stopped on day 3. TEE revealed severe mitral regurgitation and a small vegetation on the posterior mitral leaflet without any evidence of abscess (Figure 1). Patient clinically responded to intravenous ceftriaxone. However, due to recurrent pneumococcal mitral valve endocarditis and severe mitral regurgitation, the patient underwent mitral valve replacement. There was a vegetation on the pledgeted suture that was placed during mitral valve repair, and the whole suture line along P2 was infected. This infected area was widely debrided. A #29 St. Jude mechanical valve was placed. The patient had an uneventful postoperative recovery and was discharged home on anticoagulation for atrial fibrillation and mechanical heart valve. He finished a 6-week course of intravenous ceftriaxone therapy. During the follow-up visit at the clinic 6 weeks later, he was found to be asymptomatic and stable.

Table 1

Laboratory test
Result
Laboratory reference

White blood cell
22,000
4000–11000 cells/cc

    Neutrophils

    Bands

    Lymphocytes

Hemoglobin
10.8

Hematocrit
32.7

Serum sodium
135
135–145 meq/dL

Serum potassium
4.4
3.5–4.5 meq/dL

Serum bicarbonate
23
22–24 meq/dL

Serum chloride
103
100–110 meq/dL

Serum creatinine
1.48
0.6–1.2 mg/dL

Blood urea nitrogen
41
8–24 mg/dL

Serum calcium
9.4
8.7–10.2 mg/dL

Blood glucose
124
140–180 mg/dL

Prothrombin time
24.8

International normalized ratio (INR)
2.3

Figure 1: Transesophageal echocardiogram. A small vegetation (white arrow) on the mitral leaflet at the site of mitral valve repair.

3. Discussion

Streptococcus pneumoniae is a normal member of the respiratory flora and its invasion often leads to pneumonia. Invasive pneumococcal disease is still a significant cause of mortality and morbidity in this 21st century [3]. Streptococcus pneumonia is recognized to be the most common cause of community-acquired pneumonia and as such, pneumococcal bacteremia is usually the sequelae of lung infection. Less commonly, it may follow sinusitis and otitis media and at times, there is no recognized focus of infection [1–4].

PE has been a rare clinical entity since the advent of penicillin in the 1940s. However, the morbidity and mortality associated with this clinical entity is high [4]. As most of the literature is derived from case reports and small case series, the incidence of PE is not exactly known but few clinical studies have estimated the prevalence to be less than 3% [1, 5, 6]. Recurrence of PE is even more rare. Very few cases of recurrent PE are reported in the medical literature. To our knowledge, the last reported case of recurrent PE was by Lindberg and Fangel in 1999 [7]. Risk factors of PE include extremes of age, alcoholism, malnutrition, immunosuppression, and prior valvulopathy. Local factors that cause impaired clearance mechanisms in the lung tissue, such as chronic tobacco use, chronic pulmonary disease, and recent lung infection, are other identified risk factors [1, 8, 9]. Alcoholism is considered to be one of the strongest risk factors for PE [9], although our patient denied any significant alcohol consumption; immunosuppression secondary to splenectomy and old age were considered to be the predisposing factors.

The most common presenting symptom of PE is fever. Diagnosis is often delayed due to concomitant infectious processes [10, 11]. PE tends to be very aggressive and is associated with substantial mortality rates. Tanawuttiwat et al. reported a case of pneumococcal mitral valve endocarditis that had a fulminant course with extremely rapid valve destruction [2]. Given its acute presentation, the peripheral stigmata of infective endocarditis are rarely seen [2, 5, 12]. It can affect either native or prosthetic valves and has a predilection for the aortic valve. The mitral valve is reported to be the second most commonly affected valve in PE [1, 4, 10]. At times, multiple valves can be affected simultaneously [1]. Our patient had recurrent acute infection of the mitral valve and did not have any signs of the peripheral stigmata of infective endocarditis on presentation during any of the three episodes.

The most frequent complications of PE in adults are congestive heart failure, large arterial emboli, and focal abscesses [4]. Given its acute presentation and rapid course, patients should be closely monitored for any complications. Echocardiogram is the cornerstone in the diagnosis of infective endocarditis [1, 4, 10]. Transthoracic echocardiograms (TTE) have been shown to detect vegetations in about 90% of cases of pneumococcal endocarditis due to its propensity to form large vegetations [1, 4]. On the other hand, the rates of the detection of complications with TTE for valvular perforation and abscess are 20% and 13%, respectively [1, 4]. TEE is far more sensitive than TTE for the detection of the extent of valve damage and, hence, TEE should be performed in all PE patients as its findings may alter the management approach [1, 4, 10].

Treatment of PE includes a prolonged course of intravenous antibiotics and, if needed, surgery [13]. Penicillin was the drug of choice for treatment of PE in the past. However, due to the increase in the incidence of penicillin-resistant strains and frequent association with meningitis [10, 14, 15], a 3rd generation cephalosporin and vancomycin are often started on admission depending on the clinical scenario. An association of PE with pneumococcal meningitis (and at times, pneumococcal pneumonia) is often referred to as Austrian syndrome. Few cases of Austrian syndrome are reported in the medical literature [16, 17]. Martínez et al. reported a concerning increase in the resistance of pneumococci to penicillin, but the study did not show any effect of penicillin-resistant strains on clinical characteristics, complications, and mortality. However, left-sided heart failure was associated with increased mortality in this study [10]. Surgical evaluation must be pursued in any PE patient with suspicion for complications like abscess, large vegetation, and valve perforation. The combined medical and surgical approach has improved outcomes, as compared to medical treatment alone in this group of patients [10, 13]. Pneumococcal vaccine should be administered to all at-risk patients to prevent complications and recurrence of PE [18, 19]. Our patient was prone to pneumococcal bacteremia and endocarditis even though pneumococcal vaccine was administered.

4. Conclusion

Our case report emphasizes that high index of suspicion for PE is required in any immunosuppressed patient who presents with high-grade fever and pneumococcal bacteremia. Early recognition with echocardiography, prompt initiation of appropriate antibiotic therapy, and surgical evaluation would help decrease mortality in this group of patients. A few studies have shown that mitral valve repair may have better long-term results in mitral valve endocarditis [20, 21]; however, our case emphasizes that mitral valve replacement may be a better option over mitral valve repair during the initial episode of pneumococcal mitral valve endocarditis in an immunosuppressed patient due to its aggressive course and propensity to recur. However, further investigation is required to support this recommendation. Although the efficacy of pneumococcal vaccine was debatable in our patient, it should be promptly administered to all susceptible patients as per standard immunization guidelines.

Conflict of Interests

There is no financial interest or conflict of interests for any of the authors associated with this paper.

References

S. I. Aronin, S. K. Mukherjee, J. C. West, and E. L. Cooney, “Review of pneumococcal endocarditis in adults in the penicillin era,” Clinical Infectious Diseases, vol. 26, no. 1, pp. 165–171, 1998.

T. Tanawuttiwat, B. Poustinchian, A. Treitman, and A. Zelinger, “Pneumococcal endocarditis with extremely rapid valve destruction in a splenectomized host,” The Journal of Heart Valve Disease, vol. 20, no. 5, pp. 596–598, 2011.

A. M. Rueda, J. A. Serpa, M. Matloobi, M. Mushtaq, and D. M. Musher, “The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century,” Medicine, vol. 89, no. 5, pp. 331–336, 2010.

A. Lefort, J.-L. Mainardi, C. Selton-Suty, P. Casassus, L. Guillevin, and O. Lortholary, “Streptococcus pneumoniae endocarditis in adults: a multicenter study in France in the era of penicillin resistance (1991–1998),” Medicine, vol. 79, no. 5, pp. 327–337, 2000.

M. Sands, R. B. Brown, M. Ryczak, and W. Hamilton, “Streptococcus pneumoniae endocarditis,” Southern Medical Journal, vol. 80, no. 6, pp. 780–782, 1987.

A. L. Straus and M. Hamburger, “Pneumococcal endocarditis in the penicillin era,” Archives of Internal Medicine, vol. 118, no. 3, pp. 190–198, 1966.

J. Lindberg and S. Fangel, “Recurrent endocarditis caused by Streptococcus pneumoniae,” Scandinavian Journal of Infectious Diseases, vol. 31, no. 4, pp. 409–410, 1999.

R. Austrian and J. Gold, “Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia,” Annals of Internal Medicine, vol. 60, pp. 759–776, 1964.

N. A. Buchbinder and W. C. Roberts, “Alcoholism. An important but unemphasized factor predisposing to infective endocarditis,” Archives of Internal Medicine, vol. 132, no. 5, pp. 689–692, 1973.

E. Martínez, J. M. Miró, B. Almirante et al., “Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults,” Clinical Infectious Diseases, vol. 35, no. 2, pp. 130–139, 2002.

G. A. W. Bruyn, J. Thompson, and J. W. M. van der Meer, “Pneumococcal endocarditis in adult patients. A report of five cases and review of the literature,” Quarterly Journal of Medicine, vol. 74, no. 273, pp. 33–40, 1990.

W. G. Powderly, S. L. Stanley Jr., and G. Medoff, “Pneumococcal endocarditis: report of a series and review of the literature,” Reviews of Infectious Diseases, vol. 8, no. 5, pp. 786–791, 1986.

J. Booker and D. Musher, “Sinusitis complicated by dural sinus thrombosis and Streptococcus pneumoniae endocarditis: a case report and review of the literature,” Journal of Infection, vol. 55, no. 2, pp. 106–110, 2007.

M. Siegel and J. Timpone, “Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review,” Clinical Infectious Diseases, vol. 32, no. 6, pp. 972–974, 2001.

C. Gonzaga and L. L. Dever, “Emergence of Penicillin resistance in recurrent pneumococcal endocarditis in an HIV-infected patient,” Microbial Drug Resistance, vol. 4, no. 1, pp. 61–63, 1998.

Y. M. Kim, S. A. Kim, M. G. Kim et al., “Austrian syndrome with a delayed onset of heart failure,” Journal of Cardiovascular Ultrasound, vol. 19, no. 1, pp. 35–37, 2011.

W. Alhushki and C. Rongkavilit, “Austrian syndrome associated with pandemic (H1N1) 2009 in child,” Emerging Infectious Diseases, vol. 16, no. 9, pp. 1493–1495, 2010.

A. Vila-Córcoles, “Advances in pneumococcal vaccines: what are the advantages for the elderly?” Drugs and Aging, vol. 24, no. 10, pp. 791–800, 2007.

O. Odiete, O. Akinwande, J. J. Murray, and J. Akamah, “Pneumococcal tricuspid valve endocarditis in a young African American: a case for inclusion of African Americans in pneumococcal vaccine criteria,” Case Reports in Medicine, vol. 2010, Article ID 982521, 2010.

L. Sternik, K. J. Zehr, T. A. Orszulak, C. J. Mullany, R. C. Daly, and H. V. Schaff, “The advantage of repair of mitral valve in acute endocarditis,” Journal of Heart Valve Disease, vol. 11, no. 1, pp. 91–97, 2002.

H. H. H. Feringa, L. J. Shaw, D. Poldermans et al., “Mitral valve repair and replacement in endocarditis: a systematic review of literature,” Annals of Thoracic Surgery, vol. 83, no. 2, pp. 564–570, 2007.